Evaluation of TNF-α Genetic Polymorphisms As Predictors for Sepsis Susceptibility and Progression

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2020 Mar 16

PMID 32171247

Citations 22

Authors

Anca Meda Georgescu

Claudia Banescu

Razvan Azamfirei

Adina Hutanu

Valeriu Moldovan

Iudita Badea

Septimiu Voidazan

Minodora Dobreanu

Ioana Raluca Chirtes

Leonard Azamfirei

Affiliations

Soon will be listed here.

Abstract

Background: The goal of the study was to evaluate a potential role for tumor necrosis factor alpha (TNF-α) genetic variability as biomarker in sepsis. In particular, we aimed to determine if single nucleotide polymorphisms (SNPs) of TNF-α gene are associated with sepsis in terms of risk, severity and outcome.

Methods: We performed a prospective study on 163 adult critically ill septic patients (septic shock 65, sepsis 98, further divided in 40 survivors and 123 deceased) and 232 healthy controls. Genotyping of TNF-α SNPs (-308G/A, -238G/A, -376G/A and +489G/A) was performed for all patients and controls and plasma cytokine levels were measured during the first 24 h after sepsis onset.

Results: TNF-α +489G/A A-allele carriage was associated with significantly lower risk of developing sepsis and sepsis shock (AA+AG vs GG: OR = 0.53; p = 0.004; 95% CI = 0.34-0.82 and OR = 0.39; p = 0.003; 95% CI = 0.21-0.74, respectively) but not with sepsis-related outcomes. There was no significant association between any of the other TNF-α promoter SNPs, or their haplotype frequencies and sepsis or septic shock risk. Circulating TNF-α levels were higher in septic shock; they were not correlated with SNP genotype distribution; GG homozygosity for each polymorphism was correlated with higher TNF-α levels in septic shock.

Conclusions: TNF-α +489G/A SNP A-allele carriage may confer protection against sepsis and septic shock development but apparently does not influence sepsis-related mortality. Promoter TNF-α SNPs did not affect transcription and were not associated with distinct sepsis, septic shock risk or outcomes.

Citing Articles

Advancing sepsis diagnosis and immunotherapy machine learning-driven identification of stable molecular biomarkers and therapeutic targets.

Xiong W, Zhan Y, Xiao R, Liu F Sci Rep. 2025; 15(1):8333.

PMID: 40065038 PMC: 11894075. DOI: 10.1038/s41598-025-93010-8.

Association between tumor necrosis factor-α gene polymorphism and interleukin-6 level with mortality of neonatal sepsis.

Darnifayanti D, Akmal M, Nur S, Yusuf S Narra J. 2025; 4(3):e1234.

PMID: 39816047 PMC: 11731679. DOI: 10.52225/narra.v4i3.1234.

The Role of Corticosteroids in Non-Bacterial and Secondary Encephalitis.

Di Flumeri G, Giaccari L, Pace M, Passavanti M, Pota V, Riccardi V Life (Basel). 2025; 14(12.

PMID: 39768405 PMC: 11679550. DOI: 10.3390/life14121699.

Risk assessment with gene expression markers in sepsis development.

Garcia Lopez A, Schauble S, Sae-Ong T, Seelbinder B, Bauer M, Giamarellos-Bourboulis E Cell Rep Med. 2024; 5(9):101712.

PMID: 39232497 PMC: 11528229. DOI: 10.1016/j.xcrm.2024.101712.

iRhom2 deficiency reduces sepsis-induced mortality associated with the attenuation of lung macrophages in mice.

Kim J, Kim J, Kim Y, Lee J, Lee H, Koh S Histochem Cell Biol. 2024; 162(5):415-428.

PMID: 39134731 PMC: 11393161. DOI: 10.1007/s00418-024-02318-5.

References

Surbatovic M, Grujic K, Cikota B, Jevtic M, Filipovic N, Romic P . Polymorphisms of genes encoding tumor necrosis factor-alpha, interleukin-10, cluster of differentiation-14 and interleukin-1ra in critically ill patients. J Crit Care. 2010; 25(3):542.e1-8. DOI: 10.1016/j.jcrc.2009.12.003. View

David V, Ercisli M, Rogobete A, Boia E, Horhat R, Nitu R . Early Prediction of Sepsis Incidence in Critically Ill Patients Using Specific Genetic Polymorphisms. Biochem Genet. 2016; 55(3):193-203. DOI: 10.1007/s10528-016-9785-2. View

Song H, Tang L, Xu M, Li H, Xu S, Li G . CD86 polymorphism affects pneumonia-induced sepsis by decreasing gene expression in monocytes. Inflammation. 2014; 38(2):879-85. DOI: 10.1007/s10753-014-9997-8. View

Brinkman B, Zuijdeest D, Kaijzel E, Breedveld F, Verweij C . Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation. J Inflamm. 1995; 46(1):32-41. View

Abraham L, Kroeger K . Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol. 1999; 66(4):562-6. DOI: 10.1002/jlb.66.4.562. View

Weitkamp J, Stuber F, Bartmann P . Pilot study assessing TNF gene polymorphism as a prognostic marker for disease progression in neonates with sepsis. Infection. 2000; 28(2):92-6. DOI: 10.1007/s150100050053. View

OKeefe G, Hybki D, Munford R . The G-->A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. J Trauma. 2002; 52(5):817-25; discussion 825-6. DOI: 10.1097/00005373-200205000-00001. View

Muresan S, Georgescu A, Azamfirei L, Marginean C, Cm Taylor D . Medical education in Romania: Tradition and innovation. Med Teach. 2019; 41(6):619-624. DOI: 10.1080/0142159X.2018.1552932. View

Zhukov N, Shirinskaia N, Dolgikh T, Akhmedov V . [Dynamics of expression of cytokines and lactoferrin in patients with chronic alcohol pancreatitis and chronic relapsing pancreatitis]. Eksp Klin Gastroenterol. 2003; (5):67-71, 194. View

10.

Azevedo Z, Moore D, Lima F, Cardoso C, Bougleux R, Matos G . Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: importance in ARDS in septic pediatric critically ill patients. Hum Immunol. 2012; 73(6):661-7. DOI: 10.1016/j.humimm.2012.03.007. View

11.

Feng B, Mao Z, Pang K, Zhang S, Li L . Association of tumor necrosis factor α -308G/A and interleukin-6 -174G/C gene polymorphism with pneumonia-induced sepsis. J Crit Care. 2015; 30(5):920-3. DOI: 10.1016/j.jcrc.2015.04.123. View

12.

Gordon A, Lagan A, Aganna E, Cheung L, Peters C, McDermott M . TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study. Genes Immun. 2004; 5(8):631-40. DOI: 10.1038/sj.gene.6364136. View

13.

Gupta D, Nagar P, Kamal V, Bhoi S, Rao D . Clinical relevance of single nucleotide polymorphisms within the 13 cytokine genes in North Indian trauma hemorrhagic shock patients. Scand J Trauma Resusc Emerg Med. 2015; 23:96. PMC: 4642631. DOI: 10.1186/s13049-015-0174-3. View

14.

Thompson C, Holden T, Rona G, Laxmanan B, Black R, OKeefe G . Toll-like receptor 1 polymorphisms and associated outcomes in sepsis after traumatic injury: a candidate gene association study. Ann Surg. 2013; 259(1):179-85. PMC: 3686843. DOI: 10.1097/SLA.0b013e31828538e8. View

15.

Wang H, Wei Y, Zeng Y, Qin Y, Xiong B, Qin G . The association of polymorphisms of TLR4 and CD14 genes with susceptibility to sepsis in a Chinese population. BMC Med Genet. 2014; 15:123. PMC: 4411696. DOI: 10.1186/s12881-014-0123-4. View

16.

Watanabe E, Zehnbauer B, Oda S, Sato Y, Hirasawa H, Buchman T . Tumor necrosis factor -308 polymorphism (rs1800629) is associated with mortality and ventilator duration in 1057 Caucasian patients. Cytokine. 2012; 60(1):249-56. PMC: 3570580. DOI: 10.1016/j.cyto.2012.06.016. View

17.

Surbatovic M, Veljovic M, Jevdjic J, Popovic N, Djordjevic D, Radakovic S . Immunoinflammatory response in critically ill patients: severe sepsis and/or trauma. Mediators Inflamm. 2013; 2013:362793. PMC: 3859159. DOI: 10.1155/2013/362793. View

18.

Schueller A, Heep A, Kattner E, Kroll M, Wisbauer M, Sander J . Prevalence of two tumor necrosis factor gene polymorphisms in premature infants with early onset sepsis. Biol Neonate. 2006; 90(4):229-32. DOI: 10.1159/000093605. View

19.

Lin Y, Chen R, Wan L, Sheu J, Huang C, Lin C . Association of TNF-alpha gene polymorphisms with systemic lupus erythematosus in Taiwanese patients. Lupus. 2009; 18(11):974-9. DOI: 10.1177/0961203309105361. View

20.

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View